Live feed
Filing
SC 13D
SC 13D0001493152-22-025758·Javitt Daniel C.
Schedule 13D ownership disclosure
NRX PHARMACEUTICALS INC
Security class unavailable · CUSIP: 629444100
Event date: 2022-07-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-025758
- Form type
- SC 13D
- Filer
- Javitt Daniel C.
- CIK
- CIK 1864534
- Filed
- Sep 13, 2022
- Reporting period
- Jul 01, 2022
- Description
- Schedule 13D beneficial ownership